Protagonist Therapeutics (NASDAQ:PTGX) is a biotechnology firm focused on discovering and developing innovative peptide-based drugs. Their operation spans the spectrum from early research to clinical development, with a particular emphasis on treating diseases by targeting the body's protein interactions. Their projects often revolve around gastrointestinal disorders, anemia, and other diseases where there is a significant unmet medical need. The objective of Protagonist Therapeutics is to leverage their proprietary technology platforms to create therapies that improve patient outcomes and potentially lead to better quality of life. The company is constantly exploring new avenues for their drug development process, aiming to expand their portfolio and impact on healthcare significantly.